The FDA’s inability to retain its inspection workforce has resulted in the agency having “a large number of relatively inexperienced investigators” and is affecting the FDA’s ability to meet its inspection goals, a government watchdog agency has concluded. According to the Government Accountability Office (GAO), the FDA needs to identify the resources and possible new authori... Read More